A journey of a thousand miles must begin with a single step. – Lao Tzu, Chinese philosopher

And we are your first step into Asia.

About Us

Regenta Pharmaceuticals is a biopharmaceutical company headquartered in Beijing, China and has an office in Singapore bringing innovative medicines to patients in China and around Asia. We target at diseases that are highly prevalent in Asia.

We strive to be the trusted partner of choice for global biopharmaceutical companies seeking to access the Asian markets. Leveraging our team’s extensive drug development expertise, combined with the increasingly favorable clinical and regulatory environment in China and in Asia, we are committed to supporting our partners to develop, register and commercialize their products in Asia.

Our Vision

At Regenta, we are passionate about transforming patients’ lives in Asia and are committed to be their life journey partner. Everything we do at Regenta Pharmaceuticals is patient centric and we live by our values.

Regenta Team

Leadership Team

Jingyun Ye, Managing Director

Jingyun was the founder of Beijing BrainPower, a leading healthcare investment fund and consulting firm. He worked at Novartis for more than 20 years. B.Sc in chemical engineering from Peking University and M.B.A from CEIBS.

YJ Ye, Head of Coporate Development

Previously YJ worked for Boehringer Ingelheim, Novartis and Bayer in Business Development in Asia Pacific. Bachelor in Medicine from China Medical University and M.B.A from University of New South Wales in Australia.

Wei Xue, COO

More than 25-year experience in general management and commercial operations. Previously serviced as VP of Fosun group, Head of Marketing at Bayer. B.Sc in Pharmacy from Beijing Medical University and M.B.A from Tsinghua University.

Board of Directors

Jingyun Ye

Jingyun was the founder of Beijing BrainPower, a leading healthcare investment fund and consulting firm. He worked at Novartis for more than 20 years. B.Sc in chemical engineering from Peking University and M.B.A from CEIBS.

YJ Ye

Previously YJ worked for Boehringer Ingelheim, Novartis and Bayer in Business Development in Asia Pacific. Bachelor in Medicine from China Medical University and M.B.A from University of New South Wales in Australia.

Peter Kayatz

Peter is the Managing Director at Waterbergh Management. He has proven achievements in drug development, M&A, management and financing. Previously he has served as Managing Director at AlcaSynn Pharmaceuticals and took the company from setup to trade sale. He held various management positions in the pharmaceutical industry. Peter is a PhD in biology and theoretical medicine.